We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adding methotrexate to adalimumab therapy significantly ...

NB-UVB phototherapy may restore adalimumab efficacy in chronic plaque psoriasis after treatment failure. Learn more about this approach.

Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...

Ustekinumab showed longer drug survival than adalimumab and secukinumab in biologic-naive psoriasis patients in Denmark. Bimekizumab, guselkumab, and risankizumab had lower discontinuation risks in ...

Children and adolescents with Crohn disease with a high body mass index may require a higher dose of adalimumab. Pediatric patients with Crohn disease (CD) with a high body mass index (BMI) are more ...

Background. Psoriasis is a chronic, potentially debilitating inflammatory skin disorder associated with erosive arthritis and an increased risk for cardiovascular disease. [1] Management strategies ...

Please provide your email address to receive an email when new articles are posted on . Patients achieved a reduction of 19.1 in HS severity when treated with combined surgery vs. a reduction of 7.8 ...

Discontinuing adalimumab increases relapse rates in patients with juvenile idiopathic arthritis (JIA)–associated uveitis. However, patients can regain inflammation control after resuming the treatment ...

Antidrug antibodies impact adalimumab treatment outcomes in psoriatic arthritis Determining the ideal blood serum level could translate to improved outcomes for patients with PsA. Undetectable levels ...

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve ...